Asper gillose pulmonaire invasive suivie d'une spondylodiscite L1–L2 au cours du traitement d'induction d'une leucemie aigue lymphoblastique. Guerison par la triple association amphotericine b, 5-fluorocytosine, itraconazole et abord direct
G Auzanneau(HIA du Val-de-Grâce à Paris), R Martoia(HIA du Val-de-Grâce à Paris), R. Carlioz(HIA du Val-de-Grâce à Paris), D Schlaifer(HIA du Val-de-Grâce à Paris), B. Dupont(Délégation Paris 5), Ph. Pernot(HIA du Val-de-Grâce à Paris)
Cited by 3
Related Papers
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
|Clinical Infectious Diseases|2003|680
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
|Clinical Infectious Diseases|2008|469
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
|The Pediatric Infectious Disease Journal|2002|436